Prostanoids for Critical Limb Ischaemia. Cochrane Database of Systematic Reviews
Article Sidebar
Main Article Content
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017 Mar 21;69(11):1465-1508.
Hardman RL, Jazaeri O, Yi J, et al. Overview of classification systems in peripheral artery disease. Semin Intervent Radiol. 2014;31(4):378-88.
Dua A, Lee CJ. Epidemiology of Peripheral Arterial Disease and Critical LimbIschemia. Tech Vasc Interv Radiol. 2016;19(2):91-5.
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD).TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg.2000;31(1 Pt 2):S1-S296.
Melillo E, Micheletti L, Nuti M, et al. Long-term clinical outcomes in critical limb ischemia--A retrospective study of 181 patients. Eur Rev Med Pharmacol Sci. 2016;20(3):502-8
Suckow BD, Goodney PP, Cambria RA, et al. Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg. 2012;26(1):67-78.
Ruffolo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia.Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006544.
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [citado 2018 sept]. The Cochrane Collaboration, 2011. Disponible en: www.cochrane-handbook.org.
Higgins JPT, Lasserson T, Chandler J, et al. Methodological Expectations of Cochrane Intervention Reviews. Cochrane: London, 2016.